Adaptive radiotherapy for lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a newer, more flexible type of radiation therapy that adjusts to changes in your body during treatment. It is for people with advanced non-small-cell lung cancer who are receiving chemotherapy alongside radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small-cell lung cancer (the most common type of lung cancer)
- Your cancer is locally advanced (stage III or higher)
- You are being treated with chemotherapy (given before or at the same time as radiation)
- You do not have small-cell lung cancer or early-stage non-small-cell lung cancer
- You or your legal representative can sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation therapy that adjusts during treatment for head and neck tumors. It’s for people who haven’t had cancer treatment before and are otherwise in good health.
This trial tests a special type of radiation therapy that can adjust to changes in your tumor during treatment. It's for people with head or neck tumors who are scheduled for radiation.
This trial tests a more precise radiation technique (stereotactic body radiotherapy) for early-stage lung cancer or small lung tumors. It aims to reduce side effects by eliminating the usual safety margin around the tumor.
This trial tests whether a newer type of daily CT scan (CBCT-guided adaptive radiotherapy) can safely and accurately deliver radiation to cancers of the prostate, cervix, bladder, lung, or head and neck. The goal is to better target the tumor and reduce side effects.
This study tests a customized (“adaptive”) way to give radiation to the chest for newly diagnosed small cell lung cancer. It aims to improve how well treatment targets the tumor while safely adjusting to tumor changes during therapy.
This trial tests a new radiation therapy machine that adjusts the radiation plan in real-time based on changes in your body. It may help make treatment more precise and reduce side effects.
Hear when a new NSCLC (Advanced Non-small Cell Lung Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.